anti-ptk7 antibody-drug conjugate skb518
Generic: Anti-PTK7 Antibody-drug Conjugate SKB518
anti-ptk7 antibody-drug conjugate skb518: 1 clinical trial tracked.
anti-ptk7 antibody-drug conjugate skb518 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anti-ptk7 antibody-drug conjugate skb518, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignancies
Primary endpoint: Objective Response Rate (ORR)
Interventionalopen290 targetStarted 2026-03Completion 2028-091 site · ChinaSichuan Kelun Pharmaceutical Research Institute Co., Ltd.